Gland Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 1,120.79 | 1,060.51 | 1,221.79 |
| Operating Expense | 699.19 | 718.47 | 742 |
| Net Profit | 281.71 | 222.92 | 321.41 |
| Net Profit Margin | 25.13 | 21.02 | 26.31 |
| Earning Per Share | 17.10 | 13.53 | 19.51 |
| EBIDTA | 419.83 | 340.86 | 469.18 |
| Effective Tax Rate | 22.85 | 22.28 | 20.98 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 1120.79 |
| Operating Expense | 699.19 |
| Net Profit | 281.71 |
| Net Profit Margin | 25.13 |
| Earning Per Share | 17.10 |
| EBIDTA | 419.83 |
| Effective Tax Rate | 22.85 |
Invest in Gland Pharma Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 4,167.43 | 3,616.53 | 4,400.71 |
| Operating Expenses Annual | 2,758.65 | 2,597.98 | 2,890.07 |
| Operating Profit Annual | 1,575.45 | 1,202.55 | 1,734.58 |
| Interest Annual | 7.84 | 7.41 | 5.24 |
| Depreciation | 157.99 | 145.68 | 109.67 |
| Net Profit Annual | 1,043.33 | 775.83 | 1,212.16 |
| Tax Annual | 362.17 | 272.58 | 406.89 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 4,167.43 |
| Operating Expenses Annual | 2,758.65 |
| Operating Profit Annual | 1,575.45 |
| Interest Annual | 7.84 |
| Depreciation | 157.99 |
| Net Profit Annual | 1,043.33 |
| Tax Annual | 362.17 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 1,905.22 | 311.18 | 491.92 |
| Cash Flow from Operations | 1,135.97 | 367.89 | 791.29 |
| Cash Flow from Investing | -2,917.58 | 1,211.22 | -1,006.92 |
| Cash Flow from Financing | -7.40 | 14.92 | 34.90 |
| Cash Flow at the End | 116.21 | 1,905.22 | 311.18 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 1,905.22 |
| Cash Flow from Operations | 1,135.97 |
| Cash Flow from Investing | -2,917.58 |
| Cash Flow from Financing | -7.40 |
| Cash Flow at the End | 116.21 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 37.80 | 33.25 | 39.42 |
| PBIT Margin (%) | 33.91 | 29.19 | 36.91 |
| PBT Margin (%) | 29.58 | 25.25 | 29.87 |
| Net PROFIT Margin (%) | 25.04 | 21.45 | 27.54 |
| Return On Networth / Equity (%) | 12.31 | 10.27 | 18.56 |
| Return On Networth /Employed (%) | 16.65 | 13.96 | 24.85 |
| Return On Assets (%) | 12.27 | 10.30 | 18.45 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.49 | 0.48 | 0.67 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 37.80 |
| PBIT Margin (%) | 33.91 |
| PBT Margin (%) | 29.58 |
| Net PROFIT Margin (%) | 25.04 |
| Return On Networth / Equity (%) | 12.31 |
| Return On Networth /Employed (%) | 16.65 |
| Return On Assets (%) | 12.27 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 1,693.73 | 1,570.55 | 1,512.19 |
| Total Current Assets Annual | 4,571.33 | 6,888.34 | 5,844.44 |
| Non Current Assets Annual | 4,969.76 | 1,884.84 | 1,989.70 |
| Total Shareholders Funds Annual | 8,995.29 | 7,953.30 | 7,158.23 |
| Total Assets Annual | 9,541.09 | 8,773.18 | 7,834.14 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 1,693.73 |
| Total Current Assets Annual | 4,571.33 |
| Non Current Assets Annual | 4,969.76 |
| Total Shareholders Funds Annual | 8,995.29 |
| Total Assets Annual | 9,541.09 |
EPS (INR)
Expected
9.92
Reported
9.93
Surprise
0.10%
Jun 2024
EPS beaten by 0.10%
Mar 2024
EPS beaten by 0.11%
Dec 2023
EPS beaten by 0.00%
